ストックスクリーナーアプリを入手
2.12
2.30%
-0.05
前日終値:
$2.17
開ける：
$2.15
24時間の取引高:
4.63M
Relative Volume:
0.53
時価総額：
$640.04M
収益：
$188.87M
当期純損益:
$-400.38M
株価収益率:
-1.4133
EPS:
-1.5
ネットキャッシュフロー:
$-260.90M
1週間 パフォーマンス:
-11.30%
1か月 パフォーマンス:
+21.84%
6か月 パフォーマンス:
+79.66%
1年 パフォーマンス:
+3.67%
1日の値動き範囲:
$2.11
$2.19
1週間の範囲:
$2.11
$2.48
52週間の値動き範囲:
$0.8511
$2.725
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
名前
Pacific Biosciences Of California Inc
セクター
電話
650-521-8000
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
PACB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.12 | 655.14M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-11 | ダウングレード | UBS | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-04-18 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-17 | アップグレード | UBS | Neutral → Buy |
| 2023-10-31 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-06-30 | 開始されました | Goldman | Buy |
| 2023-05-10 | 開始されました | Barclays | Equal Weight |
| 2023-03-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2023-01-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Neutral |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 開始されました | Cowen | Outperform |
| 2017-11-03 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | ダウングレード | CL King | Buy → Neutral |
| 2016-11-03 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2016-06-27 | 開始されました | CL King | Buy |
| 2016-04-15 | 開始されました | First Analysis Sec | Overweight |
| 2016-02-04 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-10-23 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-02-04 | 繰り返されました | Maxim Group | Buy |
| 2013-09-26 | 繰り返されました | Maxim Group | Buy |
| 2013-01-14 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Pacific Biosciences Of California Inc (PACB) 最新ニュース
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%Here's Why - MarketBeat
Pacific Biosciences accelerates sequencing with HiFi advancements - Traders Union
Aug Swings: How Pacific Biosciences of California Inc stock reacts to Fed rate cutsJuly 2025 Breakouts & Fast Moving Stock Trade Plans - moha.gov.vn
EPS Watch: How Pacific Biosciences of California Inc stock valuations compare to rivalsStop Loss & Reliable Trade Execution Plans - moha.gov.vn
Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.8%Should You Sell? - MarketBeat
Pacific Biosciences of California Inc Stock Analysis and ForecastOptions Trading Strategies & Affordable Market Strategies - earlytimes.in
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S Is Still On The Mark Following 26% Share Price Bounce - simplywall.st
Geode Capital Management LLC Increases Position in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Is Pacific Biosciences of California Inc. stock oversold or undervaluedJuly 2025 Rallies & Safe Swing Trade Setup Alerts - Newser
How Pacific Biosciences of California Inc. (P09) stock reacts to Fed tighteningEarnings Overview Summary & Weekly Top Stock Performers List - Newser
Is Pacific Biosciences of California Inc. (P09) stock undervalued historicallyWeekly Trend Recap & Community Trade Idea Sharing Platform - Newser
Will Pacific Biosciences of California Inc. (P09) stock beat revenue estimates2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Why PacBio (PACB) Stock Is Up Today - Yahoo Finance
Pacific Biosciences (PACB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Pacific Biosciences of California advances RNA sequencing in lung cancer research - Traders Union
Buy Signal: Will Pacific Biosciences of California Inc stock maintain dividend yieldJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Does Pacific Biosciences of California Inc. (P09) stock trade below intrinsic valueMarket Risk Summary & Fast Moving Market Watchlists - Newser
Why Pacific Biosciences of California Inc. (P09) stock remains top rated2025 Earnings Impact & Fast Moving Trade Plans - Newser
How higher bond yields impact Pacific Biosciences of California Inc. (P09) stockJuly 2025 Market Mood & Safe Swing Trade Setups - Newser
XTX Topco Ltd Has $1.18 Million Stock Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference - marketscreener.com
PacBio (NASDAQ: PACB) schedules fireside chat at Piper Sandler 37th Annual Healthcare Conference - Stock Titan
Is Pacific Biosciences of California Inc. stock safe for conservative investorsMarket Activity Summary & Low Drawdown Investment Strategies - moha.gov.vn
How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment - Yahoo Finance
Pacific Biosciences of California Insiders Made A Wise Decision By Selling US$864k Worth Of Stock - simplywall.st
Pullback Watch: Is Pacific Biosciences of California Inc. stock cheap compared to fundamentalsPortfolio Value Report & Real-Time Stock Entry Alerts - moha.gov.vn
Pacific Biosciences of California, Inc.Common Stock (NQ: PACB - Markets Financial Content
How risky is Pacific Biosciences of California Inc. stock now2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
PACB Shares Climb as Market Adjusts to New Forecasts - timothysykes.com
Pacific Biosciences of California, Inc. $PACB Shares Sold by Edmond DE Rothschild Holding S.A. - MarketBeat
Pacific Biosciences of California: HiFi sequencing resolves genome complexities - Traders Union
Pacific Biosciences stock delivers 70% return after InvestingPro’s undervalued call By Investing.com - Investing.com Australia
PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Finviz
PacBio Gains Traction with New Sequel II CNDx Approval in China - StocksToTrade
PacBio’s Strategic Steps: China’s Approval and HiFi Sequencing Insights Boost Confidence - timothysykes.com
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
What analysts say about Pacific Biosciences of California Inc P09 stockRetail Trading Trends & Low Entry Cost Capital - earlytimes.in
PacBio Stock May Gain Following the Collaborated Launch of GutID - MSN
What analysts say about Pacific Biosciences of California Inc stock - earlytimes.in
Can Dev Information Technology Limited Outperform Peers After Recent PullbackMarket Depth Overview & Low Risk Investment Tips - earlytimes.in
PacBio Stock Soars: Time to Dive In? - StocksToTrade
Pacific Biosciences of California launches HiFi guide to enhance lab workflows - Traders Union
PacBio’s Regulatory Triumph in China Fuels Market Optimism - timothysykes.com
$PACB stock is up 13% today. Here's what we see in our data. - Quiver Quantitative
PacBio’s New Regulatory Approval Fuels Expansion Hopes - timothysykes.com
Pacific Biosciences partners with SPT Labtech to enhance automation - Traders Union
Will Pacific Biosciences of California Inc. stock split again soon2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Pacific Biosciences Of California Inc (PACB) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.28%
大文字化:
|
ボリューム (24 時間):